Searched for
ERLOCIP
Cipla's U-turn: Happily ever after?In a foes-turn-friends move announced on February 27, the Mumbai-based drug maker announced that it will partner Swiss biotech company Roch...- Cipla weighs legal options after Delhi HC's patent rulingDrug major Cipla is exploring all legal options in the wake of Delhi High Court's ruling that it has infringed Swiss drug major Hoffman-La ...
- Delhi HC upholds Roche's patent claims on Tarceva against CiplaIn a statement to ET, Roche said it welcomed the decision of the court, which has upheld the patent covering erlotinib hydrochloride.
- Cipla slashes prices of 3 cancer drug by up to 63%The company said on Thursday that its lung cancer drug Erlocip would cost Rs 9,900 for 30 tablets instead of Rs 27,000 and Rs 3,700 for 10 ...
- Pfizer to appeal India decision to revoke cancer drug patentPfizer Ltd, the India unit of US drugmaker Pfizer Inc, will challenge the country's patent office for revoking a patent for its cancer drug...
- Cipla’s patent win against Roche boosts hopes of generic drugmakersThe Delhi HC ruling favouring India’s second largest drugmaker Cipla has come as a shot in the arm for other generic makers who are fightin...
- Cipla wins cancer drug patent caseCipla says it has scored a "landmark" court win in a patent challenge launched by Switzerland's Roche Holding over its version of a lung-ca...
- Seven stocks likely to be in action in Saturday tradeThe Indian markets are likely to open begin the special trading session in the positive terrain. Following are the stocks that are likely t...
- Delhi High Court dismisses Roche's patent suit against CiplaThe Delhi HC dismissed Hoffmann-La Roche's suit accusing Cipla of infringing the Swiss company's patent for its lung cancer medicine Tarcev...
- Cipla has not infringed F Hoffman La-Roche's patent cancer drug: High CourtThe Delhi HC held that Indian pharma major Cipla has not infringed upon the patent right of Swiss drug co F Hoffman La-Roche on a cancer dr...
- Cipla in talks with Centre to share cancer drug know-howPharma powerhouse Cipla has started talks with the government to share knowledge on making cancer drugs, which, if successful, could radica...
Load More
